Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

India’s NPPA slashes essential drug prices by up to 50%

January 26, 2017 Sales and Marketing India, nppa, pricing

India’s governmental regulatory agency, the National Pharmaceutical Pricing Authority (NPPA), has addressed the pricing of 33 medicines including antibiotics and …
News

J&J finally seals $30 billion deal for Actelion

January 26, 2017 Sales and Marketing Actelion, Janssen, Johnson & Johnson

Johnson & Johnson has, as expected, wrapped up the deal to acquire Actelion in a deal worth $30 billion, working …
News

Takeda UK names new market access director

January 25, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda

Takeda UK has appointed Peter Wheatley Price to the role of market access director, where he will also sit on …
Appointment

MHRA accepts Roche’s Tecentriq into Early Access to Medicines scheme

January 25, 2017 Research and Development, Sales and Marketing MHRA, Roche, eams, tecentriq

Roche’s Tecentriq (atezolizumab) has scored another positive opinion, this time from the Medicines and Healthcare products Regulatory Agency (MHRA), which …
News

Pharmafocus January/February is now live!

January 24, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, digital edition

Inside this issue…
News

Roche’s Actemra granted Priority Review by FDA

January 24, 2017 Manufacturing and Production, Sales and Marketing Actemra, FDA, Roche, priority review

Roche’s drug, Actemra (also known as RoActemra in Europe), has been granted priority review designation by the FDA for the …
News

Thinking big data

January 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Data, IBM Watson Health, ibm

The potential solutions offered by ‘big data’ seems to offer a vision of the future but potential solutions aren’t enough …
Feature

Rival to EpiPen to be made available to many for free

January 23, 2017 Manufacturing and Production, Sales and Marketing Kaleo, Mylan, epipen, rival

Mylan has been under scrutiny over its pricing policy with its branded EpiPen; the pressure told and led to them …
News

CEPI backed by Bill Gates raises funds to combat epidemics

January 23, 2017 Medical Communications, Sales and Marketing Bill & Melinda Gates foundation, Bill Gates, CEPI

CEPI, the Coalition for Epidemic Preparedness Innovations, have launched the beginning of its fundraising initiative – with the aim of …
News

Leaflets offering gold coins for paediatricians appear at Bengaluru event

January 23, 2017 Medical Communications, Sales and Marketing India, PEDICON

Pharmaceutical firms in India are not allowed to offer any kind of reimbursement for privileging certain treatment over others, this …
News

Artificial skin development has implications for clinical trials

January 23, 2017 Medical Communications, Sales and Marketing Seoul National University Hospital, artificial skin, dermatology

Researchers from Seoul National University Hospital have announced that it has developed a microchip that has been designed to replicate …
News

BMS receives $625 million patent settlement boost from Merck

January 23, 2017 Sales and Marketing BMS, MSD, Merck, keytruda, opdivo

Bristol-Myers Squibb were in desperate need of releasing good news after the brief announcement that it would no longer be …
News

Company in 85,000% infant epilepsy drug price increase receives $100 million fine

January 23, 2017 Sales and Marketing Mallinckrodt, Martin Skhreli

Mallinckrodt Pharmaceuticals has hit the headlines for particularly dispiriting reasons – with further evidence of practise by some companies that …
News

J&J’s Imbruvica scores fifth FDA lymphoma approval

January 20, 2017 Medical Communications, Research and Development, Sales and Marketing FDA, Marginal Zone Lymphoma, imbruvica

Johnson & Johnson’s Imbruvica (ibrutinib) has scored its fifth indication approval in the US for the treatment of Marginal Zone …
News

Top Ten most popular articles on Pharmafile.com this week

January 20, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday, and there have been some big revelations for the pharma industry this week. Brexit, the ever-present hot topic …
News
The Gateway to Local Adoption Series

Latest content

Major funding opportunity opens for early cancer diagnostics

September 4, 2026

Androlabs receives UK authorisation for new Testavan presentation

September 4, 2026

CEPI backs African-led Bundibugyo Ebola vaccine development

September 3, 2026

Cytomos appoints life sciences executive to board

September 2, 2026

Cell therapy partnership aims to bring liver disease treatment closer to US patients

September 1, 2026